Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Breast 2

Conditions

Colorectal Neoplasms 3Patient Preference 1Diabetes Mellitus 1Coronary Disease 1Breast Neoplasms 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Risk Assessment × Gastrointestinal × Clear all
NCT03819920 2019-02-05

Does Knowing One's Estimated Colorectal Cancer Risk Influence Screening Behavior?

Stanford University

Phase NA Completed
229 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01468675 2017-04-28

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

Brigham and Women's Hospital

Phase NA Completed
6,075 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Coronary Disease, Diabetes Mellitus, Colorectal Neoplasms

NCT01596582 2017-03-21

Risk Stratification to Promote Effective Shared Decision-Making for Colorectal Cancer Screening

Boston Medical Center

Phase NA Completed
352 enrolled 19 charts
Gastrointestinal

Colorectal Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡